Niosomal daunorubicin with reduced toxicity and improved anticancer activity in Swiss mice bearing fibrosarcoma

Indian Drugs

Volumn 38, Issue 1, 2001, Pages 21-26

  Sunil, Agrawal ^a   D'Souza, R ^a   Udupa, N ^a   Guruprasad, K ^b   Uma Devi, P ^b  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Antitumor activity; Daunorubicin hydrochloride; Dichloromethane injection method; Entrapment efficiency; Niosomes; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; DAUNORUBICIN; DICHLOROMETHANE; DRUG CARRIER; NIOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; FEMALE; FIBROSARCOMA; IN VITRO STUDY; INJECTION; MALE; MOUSE; NONHUMAN; SOLID TUMOR;

EID: 6644228815     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gabizon A., Goren D., Fuks Z., Barenholz A., Dagan A. and Meshorer A.; Cancer Res. (1982), 43 (4730-4735).
2. Olson F., Mayhew E., Maslow D., Rustum Y. and Szoka F.; Eur. J. Cancer Clin. Oncol. (1982), 18 (167-176).
3. Rahman A., Kessler A., More N., Sikic B., Rowden G., Woolev P. and Schein P.; Cancer Res. (1980), 40 (1532-1537).
4. Alving C.R.; Pharmacol. Ther. (1983), 22 (407-424).
5. Lasic D.D.; J. Colloid Interface Sci. (1990), 140 (302-304).
6. Rahman A., White G., More N. and Schein P.S.; Cancer Res. (1985), 45 (796-803).
7. Raja Naresh R.A., Udupa N. and Uma Devi P.; J. Pharm. Pharmacol. (1996), 48 (1128-1132).
8. Singh U.V., Bisht K.S., Uma Devi P. and Udupa N.; Pharm. Sci. (1996), 2 (407-409).
9. Kini D. P., Pandey S., Shenoy B.D., Singh U.V., Udupa N., Nagaraj K., Kamath R., Uma Devi P. and Ramnarayan K.; Indian J. Exp. Biol. (1997), 35 (373-379).
10. Rogerson A., Cummings J. and Florence A. T.; J. Microencapsulation (1987), 4 (321-328).
11. Azmin M.N., Florence A.T., Handjani-Vila R.M., Stewert J.F., Vanlerberghe G, and Whittaker J. S.; J. Pharm. Pharmacol. (1985), 37 (237-242).
12. Baillie A.J., Florence A.T., Hume L.R., Muirhead G.T. and Rogerson A.; J. Pharm. Pharmacol. (1985), 37 (863-868).
13. Hand-jani-Vila R.M., Rlbier A., Randot B. and Vanlerberghe G.; Int. J. Cosmetic Sci. (1979), 1 (303-314).
14. Talsma H., Steenbergen M.J.V., Borchert J.C.H. and Crommelin D.J.A.; J. Pharm. Sci. (1994), 83 (276-280).
15. Gabizon A.A. and Papahajopoulous D.; Proc. Natl Acad. Sci. (1988), 85 (6949-6953).